Sakai Chemical Industry Co., Ltd. AI Stock Analysis
Want to see JP:4078 full AI Analyst Report?
Sakai Chemical Industry Co., Ltd. (4078) AI Stock Analysis
Sakai Chemical Industry Co., Ltd.
(TSE/TYO:4078)
The overall score of 58 reflects a company with a strong, low-risk financial foundation that is currently facing operational headwinds and negative market momentum. The primary support comes from a robust balance sheet and attractive 3.89% dividend yield. However, these positives are significantly offset by weak net profitability and a bearish technical trend, with the stock trading below key moving averages and showing negative momentum. The company is financially stable but lacks near-term positive catalysts.
Sakai Chemical Industry Co., Ltd. (4078) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 55.44B
- Dividend Yield
- 4.83%
- Average Volume (3M)
- 167.02K
- Price to Earnings (P/E)
- 22.1
- Beta (1Y)
- 1.29
- Revenue Growth
- 1.45%
- EPS Growth
- -60.28%
- Country
- Japan
- Employees
- 1,942
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Sakai Chemical Industry Co., Ltd. Business Overview & Revenue Model
Company Description
Sakai Chemical Industry Co., Ltd., a Japanese enterprise, manufactures and distributes a broad spectrum of chemical products. Its extensive portfolio encompasses titanium dioxide, employed in diverse applications including paints, printer inks, paper...
How the Company Makes Money
Sakai Chemical Industry makes money primarily by manufacturing and selling chemical materials to business customers. Key revenue streams include: (1) Pigments/materials sales—most notably titanium dioxide, which is sold as a white pigment and opacity...
Sakai Chemical Industry Co., Ltd. Financial Statement Overview
Summary
Financial performance is mixed. The balance sheet is a clear strength with low leverage (D/E 0.21) and solid equity. Cash flow generation has improved significantly, with operating cash flow reaching a high of ¥14.5B. However, the income statement is a drag, showing stagnant revenue and a sharp drop in net income to ¥2.8B, resulting in a weak net margin of 3.4%. The overall picture is one of financial stability offset by weak profitability.
Income Statement
48NeutralBalance Sheet
75PositiveCash Flow
70Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.78B | 81.45B | 84.41B | 82.11B | 83.86B | 80.14B |
| Gross Profit | 20.53B | 20.70B | 20.17B | 16.73B | 18.34B | 21.05B |
| EBITDA | 10.07B | 10.19B | 9.85B | 7.42B | 8.96B | 11.96B |
| Net Income | 3.47B | 2.75B | 5.01B | -7.09B | 2.34B | 6.75B |
Balance Sheet | ||||||
| Total Assets | 119.81B | 117.22B | 123.32B | 125.44B | 128.02B | 123.92B |
| Cash, Cash Equivalents and Short-Term Investments | 17.72B | 15.50B | 16.42B | 16.71B | 12.41B | 10.88B |
| Total Debt | 12.52B | 16.00B | 21.92B | 27.04B | 21.64B | 16.96B |
| Total Liabilities | 36.12B | 38.29B | 43.93B | 49.98B | 43.30B | 41.21B |
| Stockholders Equity | 82.47B | 77.71B | 78.29B | 74.39B | 80.49B | 78.85B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 8.41B | 5.06B | 2.84B | -1.89B | 1.50B |
| Operating Cash Flow | 0 | 14.48B | 12.01B | 6.87B | 773.00M | 6.57B |
| Investing Cash Flow | 0 | -4.64B | -5.71B | -3.96B | -2.62B | -1.65B |
| Financing Cash Flow | 0 | -10.59B | -6.88B | 1.26B | 3.28B | -5.65B |
Sakai Chemical Industry Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4078, the sentiment is Negative. The current price of 3350.00 is below the 20-day moving average (MA) of 3408.00, below the 50-day MA of 3563.66, and below the 200-day MA of 3778.67, indicating a bearish trend. The MACD of -98.90 indicates Positive momentum. The RSI at 43.18 is Neutral, neither overbought nor oversold. The STOCH value of 47.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4078.
Sakai Chemical Industry Co., Ltd. Peers Comparison
Overall Rating
JP:400877Outperform
JP:436277Outperform
JP:418773Outperform
JP:441062Neutral
JP:410961Neutral
JP:407858Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | JPY 91.54B | 9.00 | ― | 4.35% | 5.36% | 39.76% | |
| 77Outperform | JPY 55.67B | 11.84 | ― | 4.09% | -4.92% | 2.95% | |
| 73Outperform | JPY 94.15B | 10.31 | 16.64% | 1.92% | 17.54% | 90.80% | |
| 62Neutral | JPY 34.80B | 8.08 | ― | 3.24% | 9.51% | 320.92% | |
| 61Neutral | JPY 56.77B | 16.79 | 7.17% | 3.97% | 3.94% | 14.76% | |
| 58Neutral | JPY 60.77B | 22.06 | ― | 4.83% | 1.45% | -60.28% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4078 | Sakai Chemical Industry Co., Ltd. | 3350.00 | 483.64 | 16.87% | |
| JP:4109 | Stella Chemifa Corporation | 4395.00 | 447.73 | 11.34% | |
| JP:4187 | Osaka Organic Chemical Industry Ltd. | 4330.00 | 591.51 | 15.82% | |
| JP:4008 | Sumitomo Seika Chemicals Co., Ltd. | 1377.00 | 359.22 | 35.29% | |
| JP:4362 | Nippon Fine Chemical Co., Ltd. | 2517.00 | -72.77 | -2.81% | |
| JP:4410 | Harima Chemicals Group, Inc. | 1393.00 | 562.62 | 67.75% |
Sakai Chemical Industry Co., Ltd. Corporate Events
Sakai Chemical Raises Fiscal 2027 Sales and Profit Forecasts
Sakai Chemical Industry raised its fiscal 2027 consolidated forecast, lifting projected net sales to ¥85.0 billion, operating profit to ¥6.5 billion, ordinary profit to ¥6.5 billion and profit attributable to owners of the parent to ¥4.6 billion. Str...
Sakai Chemical Reports Higher Sales and Operating Profit
Sakai Chemical Industry reported consolidated net sales of ¥43.0 billion for the six months ended September 2026, up 6.6% year on year, while operating profit increased 6.3% to ¥3.489 billion and ordinary profit rose 9.3% to ¥3.572 billion. Profit at...
Sakai Chemical Completes Stock Rights Exercise, Raises ¥2.0 Billion for M&A
Sakai Chemical Industry Co., Ltd. has reported the full exercise of its fourth series stock acquisition rights, originally issued in June 2023 and allotted to SH1, L.P., resulting in the issuance of 1,012,600 new shares and raising 1,999,885,000 yen....
Sakai Chemical Completes ¥6.07 Billion Share Buyback and Plans Cancellation
Sakai Chemical Industry Co., Ltd. has completed a previously authorized share buyback program conducted under Article 459, paragraph (1) of the Companies Act and its Articles of Incorporation. The latest tranche, executed between September 1 and Sept...
Sakai Chemical Advances Share Buyback, Plans Cancellation of Treasury Stock
Sakai Chemical Industry has reported the results of its ongoing share buyback program authorized under its Articles of Incorporation and Japan’s Companies Act. Between August 1 and August 31, 2026, the company repurchased 734,700 common shares throug...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 26, 2026
